Fabrice Antigny

4.4k total citations · 1 hit paper
84 papers, 2.9k citations indexed

About

Fabrice Antigny is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Fabrice Antigny has authored 84 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Pulmonary and Respiratory Medicine, 28 papers in Cardiology and Cardiovascular Medicine and 21 papers in Molecular Biology. Recurrent topics in Fabrice Antigny's work include Pulmonary Hypertension Research and Treatments (50 papers), Ion Channels and Receptors (20 papers) and Cystic Fibrosis Research Advances (11 papers). Fabrice Antigny is often cited by papers focused on Pulmonary Hypertension Research and Treatments (50 papers), Ion Channels and Receptors (20 papers) and Cystic Fibrosis Research Advances (11 papers). Fabrice Antigny collaborates with scholars based in France, Switzerland and United States. Fabrice Antigny's co-authors include Marc Humbert, Frédéric Perros, Maud Frieden, Frédéric Becq, Clarisse Vandebrouck, Benoît Ranchoux, David Montani, Peter Dorfmüller, Jessica Sabourin and Gérald Simonneau and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Fabrice Antigny

79 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension

2015 437 citations Benoît Ranchoux, Fabrice Antigny et al. Circulation profile →

Peers

Countries citing papers authored by Fabrice Antigny

Since Specialization

Citations

This map shows the geographic impact of Fabrice Antigny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrice Antigny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrice Antigny more than expected).

Fields of papers citing papers by Fabrice Antigny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrice Antigny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrice Antigny. The network helps show where Fabrice Antigny may publish in the future.

Co-authorship network of co-authors of Fabrice Antigny

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrice Antigny. A scholar is included among the top collaborators of Fabrice Antigny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrice Antigny. Fabrice Antigny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Drugs targeting novel pathways in pulmonary arterial hypertension 2025 ·European Respiratory Journal ·Olivier Sitbon, Athénaïs Boucly, Jason Weatherald, Fabrice Antigny, Christophe Guignabert, Mitja Jevnikar, Xavier Jaïs, Laura Price, Martin R. Wilkins, Roham T. Zamanian, Laurent Savale, David Montani, Marc Humbert	2
2	TRPC channels contribute to endothelial dysfunction in pulmonary arterial hypertension 2025 ·Respiratory Research ·(unknown), (unknown), (unknown), Mary Dutheil, (unknown), Gilles Carpentier, (unknown), Jessica Sabourin, Marc Humbert, Olaf Mercier, Grégoire Ruffenach, David Montani, Véronique Capuano, Fabrice Antigny	0
3	Association of Pulmonary Hypertension With Trastuzumab Emtansine 2024 ·CHEST Journal ·(unknown), (unknown), Nicolas Favrolt, Marie‐Camille Chaumais, (unknown), Étienne-Marie Jutant, Benoît Lechartier, (unknown), (unknown), S. Palat, (unknown), Fabrice Antigny, Vincent Cottin, Guillaume Beltramo, Marc Humbert, Charles Khouri, Philippe Bonniaud, David Montani	2
4	Pulmonary vascular phenotype identified in patients withGDF2(BMP9) orBMP10variants: an international multicentre study 2024 ·European Respiratory Journal ·(unknown), Harm Jan Bogaard, Mélanie Eyries, Olivier Meyrignac, Laurent Savale, Xavier Jaïs, Maria‐Rosa Ghigna, (unknown), Lilian J. Meijboom, Arjan C. Houweling, Marilyne Lévy, Fabrice Antigny, Ari Chaouat, Vincent Cottin, Christophe Guignabert, Florence Coulet, Olivier Sitbon, Damien Bonnet, Marc Humbert, David Montani	9
5	Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular Function 2024 ·International Journal of Molecular Sciences ·(unknown), Pedro Mendes‐Ferreira, Rui Adão, (unknown), (unknown), (unknown), (unknown), (unknown), Steeve Provencher, Sébastien Bonnet, David Montani, Frédéric Perros, Fabrice Antigny, Adelino Leite‐Moreira, Carmen Brás‐Silva	4
6	Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors 2024 ·European Respiratory Journal ·(unknown), Charles Khouri, (unknown), Xavier Jaïs, Laurent Savale, Marie‐Camille Chaumais, (unknown), Mitja Jevnikar, Athénaïs Boucly, Fabrice Antigny, Frédéric Perros, Gérald Simonneau, Olivier Sitbon, Marc Humbert, David Montani	7
7	Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart 2023 ·The Journal of Physiology ·(unknown), (unknown), Rui Adão, Carmen Brás‐Silva, Mélanie Eyries, Francisco Pérez‐Vizcaíno, Véronique Capuano, David Montani, Fabrice Antigny	5
8	Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension 2022 ·Biomolecules ·(unknown), (unknown), Carmen Brás‐Silva, Fabrice Antigny, Rui Adão	18
9	SUR1 As a New Therapeutic Target for Pulmonary Arterial Hypertension 2022 ·American Journal of Respiratory Cell and Molecular Biology ·(unknown), (unknown), Véronique Capuano, Mary Dutheil, (unknown), Angèle Boët, Maria‐Rosa Ghigna, Vincent de Montpréville, Barbara Girerd, Mélanie Lambert, Olaf Mercier, Wendy K. Chung, Marc Humbert, David Montani, Fabrice Antigny	17
10	Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure 2021 ·Cells ·Thaïs Hautbergue, Fabrice Antigny, Angèle Boët, François Haddad, (unknown), Mélanie Lambert, Amélie Delaporte, (unknown), Laurent Savale, Jérôme Le Pavec, Élie Fadel, Marc Humbert, Christophe Junot, François Fenaille, Benoît Colsch, Olaf Mercier	18
11	Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload 2021 ·Cardiovascular Research ·Mélanie Lambert, Pedro Mendes‐Ferreira, Maria‐Rosa Ghigna, (unknown), Rui Adão, Angèle Boët, Véronique Capuano, Catherine Rücker‐Martin, Carmen Brás‐Silva, Rozenn Quarck, Valérie Domergue, Jean‐Luc Vachiéry, Marc Humbert, Frédéric Perros, David Montani, Fabrice Antigny	24
12	Sex and gender in pulmonary arterial hypertension 2021 ·European Respiratory Review ·(unknown), (unknown), Fabrice Antigny, Barbara Girerd, (unknown), Marie‐Camille Chaumais, Xavier Jaïs, Laurent Bertoletti, Olivier Sitbon, Jason Weatherald, Marc Humbert, David Montani	56
13	Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertension 2020 ·Archives of cardiovascular diseases ·Fabrice Antigny, Olaf Mercier, Marc Humbert, Jessica Sabourin	20
14	SUR1/Kir6.2 potassium channel a new actor involved in pulmonary arterial hypertension 2020 ·Archives of Cardiovascular Diseases Supplements ·(unknown), Angèle Boët, Mélanie Lambert, Wendy K. Chung, David Montani, Marc Humbert, Fabrice Antigny	2
15	NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension 2018 ·Circulation ·Sébastien J. Dumas, Gilles Bru‐Mercier, Audrey Courboulin, (unknown), Catherine Rücker‐Martin, Fabrice Antigny, Morad K. Nakhleh, Benoît Ranchoux, Elodie Gouadon, (unknown), (unknown), Nicolas Raymond, Peter Dorfmüller, Élie Fadel, Frédéric Perros, Marc Humbert, Sylvia Cohen‐Kaminsky	80
16	Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension breakdown → 2015 ·Circulation ·Benoît Ranchoux, Fabrice Antigny, Catherine Rücker‐Martin, Aurélie Hautefort, Christine Péchoux, Harm Jan Bogaard, Peter Dorfmüller, (unknown), Florence Lecerf, (unknown), Sophie Chat, Élie Fadel, Amal Houssaïni, Ignacio Anegón, Serge Adnot, Gérald Simonneau, Marc Humbert, Sylvia Cohen‐Kaminsky, Frédéric Perros	437
17	miR-223 reverses experimental pulmonary arterial hypertension 2015 ·American Journal of Physiology-Cell Physiology ·Jolyane Meloche, (unknown), François Potus, (unknown), Benoît Ranchoux, (unknown), Fabrice Antigny, Ève Tremblay, Sandra Breuils‐Bonnet, Frédéric Perros, Steeve Provencher, Sébastien Bonnet	102
18	Nebivolol for Improving Endothelial Dysfunction, Pulmonary Vascular Remodeling, and Right Heart Function in Pulmonary Hypertension 2015 ·Journal of the American College of Cardiology ·Frédéric Perros, Benoît Ranchoux, Mohamed Izikki, (unknown), Chris Happé, Fabrice Antigny, Philippe Jourdon, Peter Dorfmüller, Florence Lecerf, Élie Fadel, Gérald Simonneau, Marc Humbert, Harm Jan Bogaard, Saadia Eddahibi	111
19	Potassium channels in pulmonary arterial hypertension 2015 ·European Respiratory Journal ·Olivier Boucherat, Sophie Chabot, Fabrice Antigny, Frédéric Perros, Steeve Provencher, Sébastien Bonnet	60
20	Activation of Transient Receptor Potential Canonical 3 (TRPC3)-mediated Ca2+ Entry by A1 Adenosine Receptor in Cardiomyocytes Disturbs Atrioventricular Conduction 2012 ·Journal of Biological Chemistry ·Jessica Sabourin, Fabrice Antigny, Elodie Robin, Maud Frieden, Eric Raddatz	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact